One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
Sintx Technologies logo
Sintx Technologies SINT
$ 1.13 -6.61%
report update icon

Quarterly report 2026-Q3
added 11-05-2026

Sintx Technologies Cash Flow 2025-2011 | SINT

Brief cash flow overview of Sintx Technologies

The comparison covers five available annual reports between 2021 and 2025.

Cash from operations is below zero at -$8.6 million, increasing dependence on cash reserves or outside financing.

Only 0 of five annual observations were positive, indicating weak repeatability.

Receivables and inventory net of payables grew by $163 thousand, absorbing resources equal to about 16% of revenue.

What the cash flows show

Taken together, Sintx Technologies's cash flow indicators point to increased dependence on reserves or outside financing.

Annual Cash Flow Sintx Technologies

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

-8.57 M -8.64 M -14.1 M -10.3 M -10.1 M -9.11 M -6.44 M -9.35 M -4.68 M -7.17 M -9.06 M -14.5 M - - -

Depreciation & Amortization

319 K 842 K 907 K 335 K 185 K 78 K 102 K 105 K 105 K 1.44 M 1.65 M 1.84 M 1.71 M - -

Accounts Payables

382 K 299 K 636 K 434 K 241 K 194 K 191 K 301 K 1.73 M 658 K 643 K 778 K - - -

Accounts Receivables

178 K 196 K 685 K 328 K 102 K 41 K 136 K 263 K 1.24 M 1.62 M 2.66 M 2.51 M - - -

Total Inventories

825 K 502 K 888 K 737 K 597 K 487 K 639 K 624 K 2.38 M 7.21 M 9.13 M 11.7 M - - -

All numbers in USD currency

Quarterly Cash Flow Sintx Technologies

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- -2.77 M -2.49 M -2.34 M -2.52 M -2.41 M -1.3 M -1.12 M -2.57 M -2.22 M -2.73 M -3.13 M -2.92 M -3.2 M -4.87 M -2.08 M -2.46 M -2.54 M -3.18 M -2.38 M -2.41 M -2.35 M -2.99 M -2.06 M -2.12 M -1.54 M -3.4 M -1.56 M -1.55 M -1.63 M -1.7 M - -7.95 M -5.93 M -2.08 M -284 K -4.4 M -3.43 M -1.83 M - -5.26 M -2.38 M -1.46 M - -7.06 M -5.32 M -2.97 M - -11.4 M - - - - - - - - - - - - - -

Depreciation & Amortization

- 9 K 8 K 8 K 8 K 2 K 1 K 1 K 2 K 1 K 1 K 1 K 1 K 2 K 1 K 1 K 1 K 2 K 1 K 2 K 1 K 1 K 1 K 1 K 2 K 1 K 1 K 1 K 2 K 1 K 1 K - 75 K 53 K 26 K 134 K - 293 K 162 K - 1.12 M 772 K 389 K - 1.26 M 841 K 428 K - 1.37 M 897 K 433 K - 1.29 M 890 K 510 K - - - - - - - -

Accounts Payables

1.7 M 934 K 571 K 382 K 203 K 183 K 438 K 299 K 153 K 331 K 448 K 636 K 481 K 502 K 486 K 434 K 289 K 372 K 490 K 241 K 169 K 154 K 397 K 194 K 157 K 96 K 173 K 191 K 166 K 295 K 254 K 301 K 301 K 301 K 301 K 1.73 M 1.16 M 1.73 M 1.73 M 658 K 658 K 658 K 658 K 643 K 643 K 643 K 643 K 778 K 778 K 778 K 778 K 3.38 M 3.38 M 3.38 M 3.38 M - - - - - - - -

Accounts Receivables

131 K 329 K 364 K 178 K 120 K 97 K 97 K 196 K 340 K 434 K 483 K 685 K 259 K 385 K 467 K 328 K 230 K 268 K 106 K 102 K 182 K 29 K 67 K 41 K 49 K 60 K 106 K 136 K 113 K 173 K 45 K 263 K 1.2 M 263 K 263 K 1.24 M 1.59 M 1.24 M 1.24 M 1.62 M 1.62 M 1.62 M 1.62 M 2.66 M 2.66 M 2.66 M 2.66 M 2.51 M 2.51 M 2.51 M 2.51 M 2.82 M 2.82 M 2.82 M 2.82 M - - - - - - - -

Total Inventories

2.56 M 2.25 M 1.39 M 825 K 447 K 355 K 425 K 502 K 463 K 1.02 M 1.18 M 888 K 1.06 M 883 K 626 K 737 K 749 K 775 K 624 K 597 K 690 K 754 K 515 K 487 K 535 K 659 K 712 K 639 K 711 K 596 K 665 K 676 K 676 K 624 K 624 K 675 K 5.67 M 2.38 M 2.38 M 7.21 M 7.21 M 7.21 M 7.21 M 9.13 M 9.13 M 9.13 M 9.13 M 11.7 M 11.7 M 11.7 M 11.7 M 10.1 M 10.1 M 10.1 M 10.1 M - - - - - - - -

All numbers in USD currency

Cash Flow Statement is one of the three key financial reports of the company Sintx Technologies, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.

Main Sections of the Cash Flow Statement
  • Operating Activities
    This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash.
  • Investing Activities
    Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign.
  • Financing Activities
    Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.

The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.

Cash flow statements of other stocks in the Medical devices sector

Issuer Price % 24h Market Cap Country
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
ViewRay ViewRay
VRAY
- 1.54 % $ 468 M usaUSA
Medigus Ltd. Medigus Ltd.
MDGS
- 10.28 % $ 55.5 M israelIsrael
Abbott Laboratories Abbott Laboratories
ABT
$ 103.08 -0.98 % $ 179 B usaUSA
Align Technology Align Technology
ALGN
$ 154.77 -3.07 % $ 11.2 B usaUSA
Vapotherm Vapotherm
VAPO
- 6.72 % $ 34 M usaUSA
Silk Road Medical, Inc Silk Road Medical, Inc
SILK
- - $ 1.07 B usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 6.66 -3.48 % $ 999 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 41.95 -2.43 % $ 62.1 B usaUSA
Natus Medical Incorporated Natus Medical Incorporated
NTUS
- 1.94 % $ 1.05 B usaUSA
Nemaura Medical Nemaura Medical
NMRD
- -17.8 % $ 2.74 M britainBritain
Butterfly Network Butterfly Network
BFLY
$ 5.39 -8.28 % $ 1.33 B usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
$ 358.56 -2.43 % $ 9.78 B usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 101.86 -1.94 % $ 59.6 B usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 5.49 13.33 % $ 3.7 M usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 2.39 2.06 % $ 98.2 M usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 7.27 -6.56 % $ 530 M israelIsrael
Medtronic PLC Medtronic PLC
MDT
$ 99.64 -1.0 % $ 128 B usaUSA
Myomo Myomo
MYO
$ 0.81 -3.74 % $ 33.9 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 69.2 -0.59 % $ 2.05 B costa-ricaCosta-rica
Insulet Corporation Insulet Corporation
PODD
$ 133.09 -3.02 % $ 9.36 B usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
$ 6.39 -3.03 % $ 193 M canadaCanada
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 126.97 -0.01 % $ 4.41 B usaUSA
Delcath Systems Delcath Systems
DCTH
$ 18.77 -2.44 % $ 672 M usaUSA
Electromed Electromed
ELMD
$ 23.03 -1.46 % $ 190 M usaUSA
Inogen Inogen
INGN
$ 5.3 -2.31 % $ 141 M usaUSA
Globus Medical Globus Medical
GMED
$ 66.85 -2.55 % $ 9.04 B usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 81.04 -0.25 % $ 1.03 B usaUSA
Penumbra Penumbra
PEN
$ 319.13 -0.27 % $ 12.4 B usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 29.85 0.05 % $ 25.9 B britainBritain
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 6.91 -5.47 % $ 196 M usaUSA
Sensus Healthcare Sensus Healthcare
SRTS
$ 2.28 -3.39 % $ 37.2 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 2.1 -1.18 % $ 258 M usaUSA
Stryker Corporation Stryker Corporation
SYK
$ 309.41 -1.24 % $ 118 B usaUSA
AxoGen AxoGen
AXGN
$ 55.74 -1.08 % $ 2.57 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 25.62 -1.42 % $ 586 M usaUSA
Quanterix Corporation Quanterix Corporation
QTRX
$ 1.95 -3.94 % $ 83.1 M usaUSA
TELA Bio TELA Bio
TELA
$ 0.69 -4.9 % $ 32.4 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 0.45 -4.57 % $ 7.62 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 4.37 -14.76 % $ 272 M usaUSA
TransMedics Group TransMedics Group
TMDX
$ 85.17 -9.42 % $ 2.9 B usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 13.25 -2.21 % $ 1.02 B usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
$ 0.23 -2.13 % $ 14.9 M israelIsrael
Tandem Diabetes Care Tandem Diabetes Care
TNDM
$ 17.2 2.35 % $ 1.17 B usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 56.41 -9.17 % $ 8.56 B usaUSA